Improving the standard of care for patients with hormone resistant prostate cancer Teresa Gamucci Sora-Frosinone Highlights in the Management of Urogenital.
Metastatic CRC: recent therapeutic developments Dott. Carlo Garufi Oncologia Medica A Istituto Regina Elena, Roma.
B-CLL DIAGNOSIS PROGNOSIS CLINICAL MANAGEMENT MRD MONITORING THERAPY.
Gian Piero Perna Il valore aggiunto di Levosimendan nella terapia dell’insufficienza cardiaca.
